ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) Trial

ClinicalTrials.gov ID: NCT03003390

Public ClinicalTrials.gov record NCT03003390. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 6:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prevention of Central Venous Catheter-associated Thrombosis in Critically Ill Children: A Multicenter Phase 2b Trial

Study identification

NCT ID
NCT03003390
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Yale University
Other
Enrollment
51 participants

Conditions and interventions

Interventions

  • Enoxaparin Drug

Drug

Eligibility (public fields only)

Age range
Up to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 4, 2017
Primary completion
Aug 15, 2019
Completion
Aug 15, 2019
Last update posted
Jul 12, 2020

2017 – 2019

United States locations

U.S. sites
6
U.S. states
4
U.S. cities
6
Facility City State ZIP Site status
Yale University Yale New Haven Health New Haven Connecticut 06520
Saint Louis Children's Hospital-Washington University School of Medicine- St Louis Missouri 63110
Weill Cornell Medicine New York New York 10065
University of Rochester Medical Center-Golisano Children's Hospital- Rochester New York 14642
Maria Fareri Children's Hospital Valhalla New York 10595
Children's Hospital of Wisconsin/Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03003390, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 12, 2020 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03003390 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →